Emerson Group announces newest associate
WAYNE, Pa. The Emerson Group is pleased to announce the addition of Liz Stefanik to the company. Stefanik will contribute to the business in the Western region, as Emerson goes direct with all customers in the region.
Stefanik brings more than 17 years experience in sales, broker management, category development and management, and business development to Emerson. She was most recently with Novartis Consumer Healthcare as a national account manager, where she managed all aspects of Safeway Corp.
Stefanik was also employed by GlaxoSmithKline for 12 years where she worked in the Chicago area, alternating roles as regional account manager and analyst. In this capacity, she moved to California, an an integral part of the team managing Safeway.
“We’re very excited about having Liz join our group. Her skills and experience will help us to continually improve our capacity to deliver the industry leading service and expertise our client partners have come to expect,” says Rick Wellinger, president of the Emerson Group.
CVS Caremark Charitable Trust awards $4.2 million in grants benefiting children with disabilities, uninsured
WOONSOCKET, R.I. CVS Caremark has announced that $4.2 million in grants have been awarded to organizations supporting children with disabilities and those who are under-insured or uninsured.
“In today’s economic climate, it’s more important than ever to support organizations that can have a positive impact on children with disabilities and their families,” stated Eileen Howard Dunn, VP of CVS Caremark Charitable Trust, “The CVS Caremark Charitable Trust selected these grant recipients because they align with our mission to promote inclusion, increase access to medical therapies and improve academic performance of children with disabilities.”
Ninety-two organizations from around the country have received the grants awarded through the CVS Caremark Charitable Trust and the CVS Caremark All Kids Can program.
For the past three years, trust grants have centered on children with disabilities aligning with the company’s All Kids Can program. The All Kids Can program is a five-year, $25 million pledge to support children with disabilities by raising awareness in schools and in local communities about the importance of inclusion, creating greater opportunities for physical activity and play, and providing access to medical rehabilitation and related services.
Among the organizations to receive grants from CVS Caremark are nonprofits that support children with autism, such as The Autism Clinic of Texas in San Antonio; programs that offer early intervention such as Bay Cove Human Services in Boston; transitional care for children in the NICU at Women and Infants Hospital of Rhode Island; and nonprofits that offer sports and physical activity programs for children with disability, including Junior Blind of America of Los Angeles.
Grant recipients also include existing All Kids Can partners Boundless Playgrounds, Easter Seals, and VSA Arts, as well as a newly-funded group of organizations that provide healthcare services to uninsured or under-insured individuals.
Rite Aid reports monthly financial results
CAMP HILL, Pa. Rite Aid Corporation on Thursday posted a 1.8% same-store sales increase for the four weeks ended April 25. April front-end same-store sales increased 3.2%, while pharmacy same-store sales, which included an approximate 453 basis points negative impact from new generic introductions, increased 1.2%.
April and March front-end sales were impacted by a later Easter this year (April 12 this year versus March 23 last year). Same-store front-end sales for the combined March and April sales period decreased 1.6%.
For the period, same-store sales excluding the acquired Brooks Eckerd stores increased 2.7% and pharmacy same-store sales increased 2.6%.
The acquired Brooks Eckerd stores were flat, compared with the prior-year period, with front-end same-store sales increasing 4.4% and pharmacy same-store sales decreasing 1.4%.
Total drug store sales for the four-week period were flat with sales of $2 billion. Prescription revenue accounted for 67.8% of drug store sales, and third party prescription revenue represented 96.3% of pharmacy sales.